首页|美国、日本和中国医疗器械软件监管制度及其改革的比较及启示

美国、日本和中国医疗器械软件监管制度及其改革的比较及启示

扫码查看
目的:研究美国、日本和中国的医疗器械软件监管制度及现状,为进一步完善中国医疗器械软件的监管制度提供参考与建议.方法:以美国、日本和中国的医疗器械软件监管制度为研究对象,通过文献研究梳理美国、日本和中国对医疗器械软件的定义、分类、注册监管制度框架.结果与结论:美国、日本的医疗器械软件监管制度均以预审评、预变更为核心监管思路,其中美国在上市前尝试取消审批流程,与跨国跨行业机构联合研究针对性审评方法;日本在上市前简化审批流程,进行针对性机构改革.这些对进一步完善中国医疗器械软件的监管制度具有参考意义.
Comparisom Enlightenment of US,Japan and China's Regulatory Systems and Reforms of Software as Medical Devices
Objective:To study the regulatory system of software as medical devices in US,Japan and China,so as to provide references and suggestions for further perfecting the regulatory system of software as medical devices in China.Methods:Taking US,Japan and China's regulatory systems of software as medical devices as the research object,the US,Japan and China's definitions,classifications and registration regulatory system framework of medical device software were sorted out through literature research.Results and Conclusion:The core ideas of regulatory systems of software as medical device in US and Japan are both based on pre-evaluation and pre-change ideas.Specifically,the US attempts to cancel the approval process before listing,research targeted review methods jointly with multinational and cross-industry institutions;Japan simplifies the approval process before listing and conducts targeted institutional reforms.Both of them may be important references for further improving China's regulatory system of software as medical device.

software as a medical devicemedical devicesoftwareregulationregistration

邹宜諠、陈云、郭谡、黄嘉琪、李文文

展开 >

中国计量科学研究院,北京 100029

中国药科大学,南京 211198

医疗器械软件 医疗器械 软件 监管 注册

2024

中国药事
中国食品药品检定研究院(中国药品生物制品检定所)

中国药事

CSTPCD
影响因子:0.844
ISSN:1002-7777
年,卷(期):2024.38(10)